UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 249

Sortiert nach

A novel Oprm1-Cre mouse maintains endogenous expression, function and enables detailed molecular characterization of μ-opioid receptor cells

PloS one, 2022-12, Vol.17 (12), p.e0270317-e0270317

2022

Volltextzugriff (PDF)

In vivo brain GPCR signaling elucidated by phosphoproteomics

Science (American Association for the Advancement of Science), 2018-06, Vol.360 (6395)

2018

Volltextzugriff (PDF)

The Kappa Opioid Receptor

1st Edition 2022, 2021

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: Role of circulating active metabolites

Clinical pharmacology and therapeutics, 2006-05, Vol.79 (5), p.461-479

2006

Volltextzugriff (PDF)

Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior

Proceedings of the National Academy of Sciences - PNAS, 2009-06, Vol.106 (26), p.10847-10852

2009

Volltextzugriff (PDF)

Reactivation of cocaine contextual memory engages mechanistic target of rapamycin/S6 kinase 1 signaling

Frontiers in pharmacology, 2022-09, Vol.13, p.976932-976932

2022

Volltextzugriff (PDF)

The kappa opioid receptor agonist U50,488H did not affect brain-stimulation reward while it elicited conditioned place aversion in mice

BMC research notes, 2020-08, Vol.13 (1), p.384-384, Article 384

2020

Volltextzugriff (PDF)

Itching-like behavior: A common effect of the kappa opioid receptor antagonist 5′-guanidinonaltrindole and the biased kappa opioid receptor agonist 6′-guanidinonaltrindole in mice

Medicine in drug discovery, 2021-09, Vol.11, p.100097, Article 100097

2021

Volltextzugriff (PDF)

Peptide-derived ligands for the discovery of safer opioid analgesics

Drug discovery today, 2024-05, Vol.29 (5), p.103950, Article 103950

2024

Volltextzugriff (PDF)

Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966

Frontiers in pharmacology, 2022-04, Vol.13, p.803331-803331

2022

Volltextzugriff (PDF)

Agonist-promoted kappa opioid receptor (KOR) phosphorylation has behavioral endpoint-dependent and sex-specific effects

Neuropharmacology, 2022-01, Vol.202, p.108860-108860, Article 108860

2022

Volltextzugriff (PDF)

Considerations on Using Antibodies for Studying the Dynorphins/Kappa Opioid Receptor System

Handbook of experimental pharmacology, 2022, Vol.271, p.23-38

2022

Volltextzugriff (PDF)

Fundamentals of the Dynorphins/Kappa Opioid Receptor System: From Distribution to Signaling and Function

Handbook of experimental pharmacology, 2022, Vol.271, p.3-21

2022

Volltextzugriff (PDF)

Development and validation of a high performance liquid chromatography quantification method of levo‐tetrahydropalmatine and its metabolites in plasma and brain tissues: application to a pharmacokinetic study

Biomedical chromatography, 2017-04, Vol.31 (4), p.np-n/a

2017

Volltextzugriff (PDF)

Preclinical Studies on Nalfurafine (TRK-820), a Clinically Used KOR Agonist

Handbook of experimental pharmacology, 2022, Vol.271, p.137-162

2022

Volltextzugriff (PDF)

Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization

Journal of leukocyte biology, 2003-12, Vol.74 (6), p.1074-1082

2003

Volltextzugriff (PDF)

Does GEC1 Enhance Expression and Forward Trafficking of the Kappa Opioid Receptor (KOR) via Its Ability to Interact with NSF Directly?

Handbook of experimental pharmacology, 2022, Vol.271, p.83-96

2022

Volltextzugriff (PDF)

Sex differences in kappa opioid pharmacology

Life sciences (1973), 2011-01, Vol.88 (1-2), p.2-16

2011

Volltextzugriff (PDF)

Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in κ opioid aversion

Neuropsychopharmacology (New York, N.Y.), 2019-04, Vol.44 (5), p.939-949

2019

Volltextzugriff (PDF)

Brain region- and sex-specific alterations in DAMGO-stimulated [35S]GTPγS binding in mice with Oprm1 A112G

Addiction biology, 2014-05, Vol.19 (3), p.354-361

2014

Volltextzugriff (PDF)

Signaling underlying kappa opioid receptor-mediated behaviors in rodents

Frontiers in neuroscience, 2022-11, Vol.16, p.964724-964724

2022

Volltextzugriff (PDF)

Synergistic antidepressant-like effects between a kappa opioid antagonist (LY2444296) and a delta opioid agonist (ADL5859) in the mouse forced swim test

European journal of pharmacology, 2016-06, Vol.781, p.53-59

2016

Volltextzugriff (PDF)

Isoquinoline alkaloids isolated from Corydalis yanhusuo and their binding affinities at the dopamine D1 receptor

Molecules (Basel, Switzerland), 2008-09, Vol.13 (9), p.2303-2312

2008

Volltextzugriff (PDF)

6′-Guanidinonaltrindole (6′-GNTI) Is a G Protein-biased κ-Opioid Receptor Agonist That Inhibits Arrestin Recruitment

The Journal of biological chemistry, 2012-08, Vol.287 (32), p.27050-27054

2012

Volltextzugriff (PDF)

Anxiety-like effects of SR141716-precipitated delta9-tetrahydrocannabinol withdrawal in mice in the elevated plus-maze

Neuroscience letters, 2010-05, Vol.475 (3), p.165-168

2010

Volltextzugriff (PDF)

1 – 25 von 249

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(239)
Mit Volltextzugriff
(229)

Publikationsform

Sprache

Englisch
(249)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

Science & Technology
(163)
Life Sciences & Biomedicine
(145)
Animals
(140)
Humans
(81)
Pharmacology & Pharmacy
(77)
Rats
(63)
Mice
(53)
Male
(51)
Biological And Medical Sciences
(46)
Receptors, Opioid, Kappa - Metabolism
(43)
Biochemistry & Molecular Biology
(41)
Cricetinae
(41)
Cho Cells
(40)
Neurosciences
(35)
Neurosciences & Neurology
(34)
Receptors, Opioid, Mu - Metabolism
(34)
Receptors, Opioid, Kappa - Agonists
(33)
Kappa Opioid Receptor
(29)
Medical Sciences
(29)
Physical Sciences
(29)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A novel Oprm1-Cre mouse maintains endogenous expression, function and enables detailed molecular characterization of μ-opioid receptor cells

In vivo brain GPCR signaling elucidated by phosphoproteomics

The Kappa Opioid Receptor

Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: Role of circulating active metabolites

Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior

Reactivation of cocaine contextual memory engages mechanistic target of rapamycin/S6 kinase 1 signaling

The kappa opioid receptor agonist U50,488H did not affect brain-stimulation reward while it elicited conditioned place aversion in mice

Itching-like behavior: A common effect of the kappa opioid receptor antagonist 5′-guanidinonaltrindole and the biased kappa opioid receptor agonist 6′-guanidinonaltrindole in mice

Peptide-derived ligands for the discovery of safer opioid analgesics

Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966

Agonist-promoted kappa opioid receptor (KOR) phosphorylation has behavioral endpoint-dependent and sex-specific effects

Considerations on Using Antibodies for Studying the Dynorphins/Kappa Opioid Receptor System

Fundamentals of the Dynorphins/Kappa Opioid Receptor System: From Distribution to Signaling and Function

Development and validation of a high performance liquid chromatography quantification method of levo‐tetrahydropalmatine and its metabolites in plasma and brain tissues: application to a pharmacokinetic study

Preclinical Studies on Nalfurafine (TRK-820), a Clinically Used KOR Agonist

Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization

Does GEC1 Enhance Expression and Forward Trafficking of the Kappa Opioid Receptor (KOR) via Its Ability to Interact with NSF Directly?

Sex differences in kappa opioid pharmacology

Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in κ opioid aversion

Brain region- and sex-specific alterations in DAMGO-stimulated [35S]GTPγS binding in mice with Oprm1 A112G

Signaling underlying kappa opioid receptor-mediated behaviors in rodents

Synergistic antidepressant-like effects between a kappa opioid antagonist (LY2444296) and a delta opioid agonist (ADL5859) in the mouse forced swim test

Isoquinoline alkaloids isolated from Corydalis yanhusuo and their binding affinities at the dopamine D1 receptor

6′-Guanidinonaltrindole (6′-GNTI) Is a G Protein-biased κ-Opioid Receptor Agonist That Inhibits Arrestin Recruitment

Anxiety-like effects of SR141716-precipitated delta9-tetrahydrocannabinol withdrawal in mice in the elevated plus-maze

Suchergebnisse filtern